Column Group LLC Long-Term Concentrated

Location: San Francisco, CA

CIK: 0001833486 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 14, 2024

Total Value: $69.58M (100.0% shares, 0.0% debt)

Holdings (6)

ORIC ORIC Pharmaceuticals Inc. 52.2%

Value $36.29M Shares 3,540,777 Est. Cost $28.69 Unrealized -65.5%

TNYA Tenaya Therapeutics, Inc. 26.1%

Value $18.14M Shares 9,400,290 Est. Cost $21.49 Unrealized -86.9%

— Surrozen, Inc. 13.9%

Value $9.705M Shares 810,088 Est. Cost $7.82 Unrealized —

— RAPT Therapeutics Inc 7.7%

Value $5.388M Shares 2,680,621 Est. Cost $19.03 Unrealized —

SGMT Sagimet Biosciences Inc. 0.1%

Value $47,558 Shares 17,169 Est. Cost $7.18 Unrealized -57.1%

RVMD Revolution Medicines Inc 0.0%

Value $2,086 Shares 46 Est. Cost $34.24 Unrealized +27.2%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ORIC	ORIC Pharmaceuticals Inc.	3,540,777	$36.29M	52.2%	$28.69	-65.5%	COM	68622P109
TNYA	Tenaya Therapeutics, Inc.	9,400,290	$18.14M	26.1%	$21.49	-86.9%	COM	87990A106
—	Surrozen, Inc.	810,088	$9.705M	13.9%	$7.82	—	COM	86889P109
—	RAPT Therapeutics Inc	2,680,621	$5.388M	7.7%	$19.03	—	COM	75382E109
SGMT	Sagimet Biosciences Inc.	17,169	$47,558	0.1%	$7.18	-57.1%	COM	786700104
RVMD	Revolution Medicines Inc	46	$2,086	0.0%	$34.24	+27.2%	COM	76155X100